Furthermore, the only two studies that evaluated this effect prospectively showed that neither anti-TNF administration nor anti-TNF drug levels during the preoperative period was associated with postoperative complications in IBD; therefore, the complete withdrawal of biological therapy during the preoperative period is not necessary to reduce the frequency of postoperative complications [28,29]. This evidence concerns the gene TNF and inflammatory bowel disease.